RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
Seeking development opportunities with novel delivery technologies for oral, topical and transdermal products
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
New Chemical Entities and innovative therapeutic targets
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
NCEs, new patented formulations and products
Respiratory; women's care; dermatology; pain relief; GI More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
UK Marketing Partner
Are you a small to medium company seeking a UK presence? More
Wound closure systems – including sealants, devices and dressings
Wound closure systems - including sealants, devices and dressings More
Acquisition of UK Hospital established brands
UK partner for strategic divestments More
Acquisition of UK Primary Care ethical brands
Strategic divestments of primary care sales focussed brands More
Injectables and oral medicines for hospital use
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets More
Seeking partners who want to divest well-established products in any therapeutic area.
If you are considering divesting one or more brands or the whole portfolio in any therapeutic or geographic area, please contact DESMA PHARMA Group for a preliminary assessment More
Displaying 1..10 of 15 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Jun 2010 - 319 pages - $2,695
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
Jun 2010 - 411 pages - $2,695
Company Financials: Acorda Therapeutics, Inc.
Jan 2010 - $75
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
May 2010 - 263 pages - $2,695
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us